Bevacizumab-containing Chemotherapy is Safe in Patients with Unresectable Metastatic Colorectal Cancer and a Synchronous Asymptomatic Primary Tumor

Cetin, Bulent; Kaplan, Mehmet; Berk, Veli; Tufan, Gulnihal; Benekli, Mustafa; Isikdogan, Abdurrahman; ÖZKAN, METİN; Coskun, Ugur; Buyukberber, Suleyman

doi:10.1093/jjco/hys175

Bevacizumab-containing Chemotherapy is Safe in Patients with Unresectable Metastatic Colorectal Cancer and a Synchronous Asymptomatic Primary Tumor

Copy For Citation

Cetin B., Kaplan M. A., Berk V., Tufan G., Benekli M., Isikdogan A., ...More

JAPANESE JOURNAL OF CLINICAL ONCOLOGY, vol.43, no.1, pp.28-32, 2013 (SCI-Expanded)

Publication Type: Article / Article
Volume: 43 Issue: 1
Publication Date: 2013
Doi Number: 10.1093/jjco/hys175
Journal Name: JAPANESE JOURNAL OF CLINICAL ONCOLOGY
Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus
Page Numbers: pp.28-32
Erciyes University Affiliated: Yes

Abstract

Surgical resection of asymptomatic primary colorectal cancer in patients presenting with synchronous unresectable metastatic disease is controversial. Concerns and controversies remain over combining cytotoxic chemotherapy with bevacizumab in this patient population.